Skip to main content

Stock Market News - VEDL, Yes Bank top gainers, Kaveri Seed rises 3%

VEDL, Yes Bank top gainers - The Sensex was down 100 points to 37,023.14 while the Nifty was trading below the 11,000-mark at 9.20 am. VEDL, Yes Bank shares emerged among the biggest gainers in the index, jumping up to 2%.  Oil futures shed some of their massive gains on Tuesday as the United States flagged the possible release of crude reserves, but the threat of military action over the attacks on Saudi oil facilities kept prices elevated and stocks under pressure. 


While equity market losses have not been large, the shaky investor confidence continues to support safe-haven assets, with gold edging higher on Tuesday and Treasury prices rising, Reuters reported.

CG Power Locked In Upper Circuit Shares of the Mumbai-based power equipment maker rose 5 percent intraday to hit an upper circuit of Rs 15.65 each. KKR Group acquired a 10 percent stake in the company for Rs 89 crore via open market transactions, according to an exchange filing. Seller for these shares for the company’s publish shareholder Vistara ITCL, which held a stake of 21.63 percent for June quarter.

Gold Update: Gold gained 1 percent on Monday after attacks on oil facilities in Saudi Arabia fueled concerns of a further escalation in Middle East tensions and pushed investors toward safe-haven assets.

MARKET NEWS - 

1. Bharti Airtel begins talks to sell stake in merged Co of Bharti Infra & Indus Towers: sources to CNBC TV18
-- ATC, Brookfield interested parties in buying a stake

-- Bharti Airtel hopes to fetch $3.2-3.5 billion

-- Talks at the initial stage, to be taken forward post-merger completion of Bharti Infra-Indus

Alert: Bharti Airtel to hold 37.2% in the merged entity

2.  Corporation Bank's board of directors has given in-principle approval for the amalgamation of the Corporation Bank into Union Bank of India.

Rupee Opens: The Indian rupee opened lower by paise 23 at 71.82 per dollar on Tuesday versus previous close 71.59.

Glenmark Pharma gets Orphan Drug Designation for GBR 1342: The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma who have received prior therapies.

TOP GAINERS & LOSERS - 

Titan, Bharti Airtel, Yes Bank, Kaveri Seed, SAIL are some of major gainers on the indices, while losers are STC, MMTC, Indiabulls Housing, BPCL, IOC and HCL Tech. Among sectors, auto, FMCG, metal, and pharma are trading higher, while selling seen in the energy, bank, infra and IT.

Kaveri Seed to consider buyback: Share price of Kaveri Seed Company added more than 2 percent on September 17 as meeting of the board of directors of the company will be held on September 24, 2019, to consider a proposal for buyback of fully paid-up equity shares of the company, quantum & mode of buyback and other matters incidental thereto, as per BSE release.


Sensex | Market News | Gold | Bank Nifty | Rupee | Top Gainers



Labels:

Comments

Post a Comment

Popular posts from this blog

Stock Market News - Budget 2020 | Removal of exemptions in new tex regime to impact life insurers, MFs

A salaried professional opting for a lower rate of tax under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. Removal of tax exemptions under Section 80C in the new tax regime could be a dampener for life insurance products as well as equity-linked savings schemes (ELSS) of mutual funds. In her Budget speech on February 1, Finance Minister Nirmala Sitharaman said a salaried professional opting for a lower tax rate under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. “The removal of 80C benefit may pose a risk to new business volumes of life insurance companies,” said Kotak Institutional Equities in a report. Life insurance Tax exemptions are an important incentive for purchase of life insurance. To be eligible for exemption under Section 80C, the sum assured has to be 10 times the annual premium. This is part of the Rs 1.5 lakh limit under ...
13 comments
Read more

Stock Market News - FDC share price at 52-week high on GMP certificate from UK health regulator

The certificate came after a recent inspection of the company's facilities in Goa. FDC  share price touched a 52-week high of Rs 222, rising more than 5 percent in the morning trade on January 3 after the company received the good manufacturing practice (GMP) certificate from the UK's health regulator. The UK's Medicines and Healthcare Products Regulatory Agency also continued with its approved status for the company's two facilities in Verna, Goa. The GMP certificate was issued after a recent inspection of the two plants. At 1018 hours, FDC was quoting at Rs 218.00, up Rs 7.30, or 3.46 percent. The share price has risen 30 percent in the last three months. GNFC share price down 2% after DoT seeks Rs 15K cr in telecom dues DoT sent the company a demand notice for Rs 15,019 crore, taking to Rs 3.13 lakh crore the amount it has sought from non-telecom companies following a Supreme Court ruling. The share price of  Gujarat Narmada Valley Fertili...
3 comments
Read more

Budget 2019 : LTCG Tax, GST, Home Loans, farmer income scheme needs to be focus

Budget 2018 was the last full-fledged budget presented by the government led by Narendra Modi. Long Term Capital Gains (LTCG) tax on profit earned from the sale of equity shares listed on a recognized stock exchange in India. The LTCG tax was re-introduced after a time gap of 14 years. The provisions were closely followed since they impacted the majority of taxpayers of the country. The tax was levied at the rate of 10 per cent (plus applicable surcharge and cess) while providing relief from gains accrued up to January 31, 2018, i.e., a mechanism was derived wherein the stock price as on 31 January 2018 was considered as the deemed cost, provided it is beneficial to the taxpayer. Following are some of the illustrative points: Treatment of compulsorily convertible instruments – The current provisions do not provide clarity on the cost to be adopted for the purpose of computation of capital gains in case of instruments that are compulsorily converted into equity sh...
1 comment
Read more